447 related articles for article (PubMed ID: 34941192)
21. LncRNA NR2F1-AS1 as a potential biomarker for prognosis in cancer patients: meta and bioinformatics analysis.
Tang L; Liu QM; Zhang S; Zhou J
Expert Rev Mol Diagn; 2023; 23(12):1263-1272. PubMed ID: 37902251
[TBL] [Abstract][Full Text] [Related]
22. The utility of long non-coding RNA ZEB1-AS1 as a prognostic biomarker in human solid tumors: A meta-analysis.
Zuo XL; Cai J; Chen ZQ; Zhang Y; Liang LH; Wang JF; Wang JG; Wu J; Mao JD
Clin Chim Acta; 2018 Oct; 485():14-20. PubMed ID: 29906419
[TBL] [Abstract][Full Text] [Related]
23. LncRNA ZEB1-AS1 expression in cancer prognosis: Review and meta-analysis.
Chen C; Feng Y; Wang X
Clin Chim Acta; 2018 Sep; 484():265-271. PubMed ID: 29885321
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological and prognostic value of SNHG6 in cancers: a systematic review and a meta-analysis.
Zhang S; Qiu D; Xie X; Shen Y
BMC Cancer; 2020 Apr; 20(1):343. PubMed ID: 32321469
[TBL] [Abstract][Full Text] [Related]
25. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
Liu X; Huang G; Zhang J; Zhang L; Liang Z
PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
[TBL] [Abstract][Full Text] [Related]
26. The clinical prognostic value of lncRNA FAM83H-AS1 in cancer patients: a meta-analysis.
Yang Q; Wang J; Zhong P; Mou T; Hua H; Liu P; Xie F
Cancer Cell Int; 2020; 20():72. PubMed ID: 32165862
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA CASC2 in solid tumors: A meta-analysis.
Liang C; Zhang J; Ge H; Xu Y; Ren S; Yue C; Li G; Wu J
Clin Chim Acta; 2018 Nov; 486():357-368. PubMed ID: 30144439
[TBL] [Abstract][Full Text] [Related]
28. The clinical prognostic value of lncRNA LINC00473 in cancer patients: A meta-analysis.
He Y; Chen Z; He J
Medicine (Baltimore); 2022 Dec; 101(52):e32465. PubMed ID: 36596056
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological and Prognostic Role of Long Noncoding RNA Linc00152 in Various Human Neoplasms: Evidence from Meta-Analysis.
Miao C; Zhao K; Zhu J; Liang C; Xu A; Hua Y; Zhang J; Liu S; Tian Y; Zhang C; Wang Y; Su S; Wang Z; Liu B
Biomed Res Int; 2017; 2017():6010721. PubMed ID: 29285514
[TBL] [Abstract][Full Text] [Related]
30. Prognostic and clinical significance of long non-coding RNA HNF1A-AS1 in solid cancers: A systematic review and meta-analysis.
Zhou X; Fan YH; Wang Y; Liu Y
Medicine (Baltimore); 2019 Dec; 98(49):e18264. PubMed ID: 31804362
[TBL] [Abstract][Full Text] [Related]
31. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.
Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y
Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672
[TBL] [Abstract][Full Text] [Related]
32. LncRNA LOXL1-AS1 expression in cancer prognosis: A meta-analysis.
Wang X; Chen Z; Zhou H; Liu W; Luo J
Medicine (Baltimore); 2022 Dec; 101(52):e32436. PubMed ID: 36596047
[TBL] [Abstract][Full Text] [Related]
33. The Long Non-Coding RNA (lncRNA) AGAP2-AS1 is Upregulated in Ovarian Carcinoma and Negatively Regulates lncRNA MEG3.
Chen J; Peng X; Dai Y
Med Sci Monit; 2019 Jun; 25():4699-4704. PubMed ID: 31233485
[TBL] [Abstract][Full Text] [Related]
34. Long noncoding AGAP2-AS1 is activated by SP1 and promotes cell proliferation and invasion in gastric cancer.
Qi F; Liu X; Wu H; Yu X; Wei C; Huang X; Ji G; Nie F; Wang K
J Hematol Oncol; 2017 Feb; 10(1):48. PubMed ID: 28209205
[TBL] [Abstract][Full Text] [Related]
35. The Prognostic Value of lncRNA MCM3AP-AS1 on Clinical Outcomes in Various Cancers: A Meta- and Bioinformatics Analysis.
Fu L; Zhang G; Wang Y; Lu T; Liu B; Jiao Y; Ma H; Ma S; Yang K; Cai H
Dis Markers; 2022; 2022():4466776. PubMed ID: 35783010
[TBL] [Abstract][Full Text] [Related]
36. High expression of long noncoding RNA LUCAT1 correlates with a poor clinical outcome in solid tumors: A systematic review and meta-analysis.
Lv P; Ye T; Yang X; Liu H; Ye Z
Pathol Res Pract; 2020 Sep; 216(9):153047. PubMed ID: 32825932
[TBL] [Abstract][Full Text] [Related]
37. LncRNA DLX6-AS1 as a potential molecular biomarker in the clinicopathology and prognosis of various cancers: a meta-analysis.
Tian S; Liu J; Kong S; Peng L
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32785606
[TBL] [Abstract][Full Text] [Related]
38. AGAP2-AS1: An Indispensable lncRNA in Tumors.
Chen J; Wang B
Mini Rev Med Chem; 2023; 23(3):336-342. PubMed ID: 35708074
[TBL] [Abstract][Full Text] [Related]
39. Expression analysis of vimentin and the related lncRNA network in breast cancer.
Mohebi M; Ghafouri-Fard S; Modarressi MH; Dashti S; Zekri A; Kholghi-Oskooei V; Taheri M
Exp Mol Pathol; 2020 Aug; 115():104439. PubMed ID: 32283061
[TBL] [Abstract][Full Text] [Related]
40. Long noncoding RNA HOXD-AS1 in various cancers: a meta-analysis and TCGA data review.
Zhang F; Chen X; Xi K; Qiu Z; Wang Y; Gui Y; Hou Y; Chen K; Zhang X
Onco Targets Ther; 2018; 11():7827-7840. PubMed ID: 30464530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
